While iNOS+ slanMo were present in 9 out of 10 post-nRCT rectal cancer tissues, TNF-α+ slanMo were detectable in 7 out of 10 tumor tissues obtained after treatment at varying percentages (Figures 6A–D). This evidence concerns the gene TNF and neoplasm.